Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Assets
Current assets:
Cash
Restricted cash, current
Cash and cash equivalents
Prepaid expenses
Accounts receivable
Inventory
Prepaid expenses and other current assets
Total current assets
Investments held in Trust Account
Cash held in Trust Account
Property and equipment, net
Deferred transaction costs
Other non-current assets
Total assets
Liabilities and Stockholders’ Deficit
Current liabilities:
Promissory note – related party
Related Party
Total promissory note – related party
Income taxes payable
Accounts payable
Accrued expenses and other current liabilities
Excise tax payable
Convertible notes, current
Nonrelated Party
Related Party
Total convertible notes, current
Related party convertible notes, current
Related Party
Total related party convertible notes, current
Operating lease liabilities, current
Share-based termination liability
Total current liabilities
Deferred underwriting fee payable
Warrant liabilities
Operating lease liabilities, non-current
Long-term debt, non-current
Long-term debt, non-current
Warrants
Public placement warrant liability
Related party private placement warrant liability
Convertible preferred stock warrants liability
Total warrants
Related party private placement warrant liability
Convertible preferred stock warrant liability
Other non-current liabilities
Total liabilities
Convertible preferred stock: $0.0001 par value, none and 12,550,441 shares authorized as of December 31, 2024 and December 31, 2023, respectively; none and 8,048,573 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; and aggregate liquidation preference of none and $222,345 as of December 31, 2024 and December 31, 2023, respectively
Convertible Preferred Stock
Total convertible preferred stock: $0.0001 par value, none and 12,550,441 shares authorized as of December 31, 2024 and December 31, 2023, respectively; none and 8,048,573 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; and aggregate liquidation preference of none and $222,345 as of December 31, 2024 and December 31, 2023, respectively
Stockholders’ Deficit:
Common stock: $0.0001 par value, 500,000,000 shares authorized at September 30, 2025 and December 31, 2024; 3,706,197 and 1,714,792 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
Class A Common Stock
Class B Common Stock
Total common stock: $0.0001 par value, 500,000,000 shares authorized at September 30, 2025 and December 31, 2024; 3,706,197 and 1,714,792 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 140,000 shares and 7,187,500 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support